Targeting MEK with the selective MEK inhibitor PD0325901, a derivative of CI-1040, had in vivo chemopreventive effects on HCC development in an animal model employing TGF-α-transgenic mice with liver cancers induced by diethylnitrosamine treatment [217]. The gene discussed is MAP2K7; the disease is liver cancer.